2. Natural Products
  3. Plants
  4. Rubiaceae
  5. Morinda officinalis How

Morinda officinalis How

 

Morinda officinalis How (33):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N2577
    1F-Fructofuranosylnystose 59432-60-9 99.95%
    1F-Fructofuranosylnystose can be used in the synthesis of Fructooligosaccharides (FOSs). Fructooligosaccharides exhibit lots of beneficial effects on our health and have been used as food ingredients.
    1F-Fructofuranosylnystose
  • HY-N1499
    Nystose 13133-07-8 99.98%
    Nystose is a tetrasaccharide with two fructose molecules linked via beta (1→2) bonds to the fructosyl moiety of sucrose. Nystose exhibits prebiotic, immunomodulatory, and metabolism regulating activities. Nystose promotes the bone mineralization by activating the Wnt/β-catenin signaling pathway.
    Nystose
  • HY-N2579
    1-Kestose 470-69-9 99.95%
    1-Kestose, the smallest fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as Bifidobacteria.
    1-Kestose
  • HY-N0648
    Monotropein 5945-50-6 99.80%
    Monotropein is an iridoid glycoside that can be isolated from the roots of Morinda officinalis. Monotropein inhibits the expression of inflammatory mediators in dextran sulfate sodium (DSS)-induced colitis mouse model. Monotropein exerts protective effects against IL-1β-induced apoptosis and catabolic responses on osteoarthritis chondrocytes. Monotropein has cartilage protective activity. Monotropein can alleviate Cisplatin (HY-17394)-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis through activation of Nrf2/HO-1 pathway and inhibition of NF-κB signaling. Monotropein can be studied in research for osteoarthritis, acute kidney injury and acute lung injury.
    Monotropein
  • HY-N6246
    Asperulosidic Acid 25368-11-0 99.63%
    Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways.
    Asperulosidic Acid
  • HY-N17498
    (+)-Mornaphthoate C 2409077-02-5
    (+)-Mornaphthoate C is a methyl 2-naphthoate derivative found in the roots of Morinda officinalis var. officinalis. (+)-Mornaphthoate C shows no significant activity against AChE or BChE at 50 μM. (+)-Mornaphthoate C exhibits no significant cytotoxicity against cancer cells.
    (+)-Mornaphthoate C
  • HY-N17319A
    (+)-Mornaphthoate D 2409077-04-7
    (+)-Mornaphthoate D is a Methyl 2-naphthoate derivative. (+)-Mornaphthoate D can be isolated from the roots of Morinda officinalis var. officinalis. (+)-Mornaphthoate D exhibits no activity against Acetylcholinesterase and Butyrylcholinesterase. (+)-Mornaphthoate D can be used in the research of non-small cell lung cancer and triple-negative breast cancer.
    (+)-Mornaphthoate D
  • HY-N17556
    (+)-Mornaphthoate B 2409077-00-3
    (+)-Mornaphthoate B is a Methyl 2-naphthoate derivative. (+)-Mornaphthoate B can be isolated from the roots of Morinda officinalis var. officinalis. (+)-Mornaphthoate B exhibits no activity against Acetylcholinesterase and Butyrylcholinesterase. (+)-Mornaphthoate B can be used in the research of non-small cell lung cancer and triple-negative breast cancer.
    (+)-Mornaphthoate B
  • HY-N0594
    Deacetylasperulosidic Acid 14259-55-3 99.44%
    Deacetylasperulosidic Acid is an orally active antioxidant. Deacetylasperulosidic Acid exerts a definite in vivo antioxidant effect and alleviates oxidative stress injury by enhancing SOD activity. In atopic dermatitis models, Deacetylasperulosidic Acid corrects Th2-skewed immune imbalance and reduces allergy-related factors; in immunosuppression models, it activates cellular immunity, enhances NK cell activity and IL-2 production. Deacetylasperulosidic Acid can be used in the research of atopic dermatitis.
    Deacetylasperulosidic Acid
  • HY-N0444
    Rubiadin 117-02-2 99.20%
    Rubiadin is an orally active polyketide-derived compound and free radical scavenger that inhibits the activation of the NF-κB pathway. Rubiadin inhibits osteoclast formation, bone resorption, lipid peroxidation, HBV DNA replication and cancer cell proliferation; reduces pro-inflammatory cytokine levels; induces cancer cell apoptosis; and possesses antifungal, antimalarial, antibacterial and anticonvulsant activities. Rubiadin can be used in the research of osteoporosis, acute inflammation, chronic inflammation, carbon tetrachloride-induced liver injury, Alzheimer's disease, breast cancer, iron overload disorders, hepatitis B virus infection, colon cancer, liver cancer, T-lymphocytic leukemia, cervical cancer, diabetic nephropathy, epileptic seizures, fungal infections, malaria and bacterial infections.
    Rubiadin
  • HY-N1499R
    Nystose (Standard) 13133-07-8
    Nystose (Standard) is the analytical standard of Nystose. This product is intended for research and analytical applications. Nystose is a tetrasaccharide with two fructose molecules linked via beta (1→2) bonds to the fructosyl moiety of sucrose. Nystose exhibits prebiotic, immunomodulatory, and metabolism regulating activities. Nystose promotes the bone mineralization by activating the Wnt/β-catenin signaling pathway.
    Nystose (Standard)
  • HY-N2579R
    1-Kestose (Standard) 470-69-9
    1-Kestose (Standard) is the analytical standard of 1-Kestose. This product is intended for research and analytical applications. 1-Kestose, the smallest fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as Bifidobacteria.
    1-Kestose (Standard)
  • HY-N17499
    (-)-Mornaphthoate C 2409077-03-6
    (-)-Mornaphthoate C is a methyl 2-naphthoate derivative found in the roots of Morinda officinalis var. officinalis. (-)-Mornaphthoate C shows no significant activity against AChE or BChE at 50 μM. (-)-Mornaphthoate C exhibits no significant cytotoxicity against cancer cells.
    (-)-Mornaphthoate C
  • HY-N17840
    6α-Methoxygeniposidic acid 134515-70-1
    6α-Methoxygeniposidic acid is an iridoid glucoside found in the leaves of Hedyotis tenelliflora Blume (Rubiaceae).
    6α-Methoxygeniposidic acid
  • HY-N17635
    Mornaphthoate F 2409077-09-2
    Mornaphthoate F is a methyl 2-naphthoate derivative that can be isolated from the roots of Morinda officinalis var. officinalis.
    Mornaphthoate F
  • HY-N17843
    3,8-Dihydroxy-1,2-dimethoxyanthraquinone 108637-83-8
    3,8-Dihydroxy-1,2-dimethoxyanthraquinone is an anthraquinone found in the roots of Morinda officinalis How. 3,8-Dihydroxy-1,2-dimethoxyanthraquinone does not inhibit LPS (HY-D1056)-stimulated NO production with an IC50 >50 μM.
    3,8-Dihydroxy-1,2-dimethoxyanthraquinone
  • HY-N17889
    2,8-Dihydroxy-1-methoxyanthracene-9,10-dione 2765538-19-8
    2,8-Dihydroxy-1-methoxyanthracene-9,10-dione is an anthraquinone that can be found in the roots of Morinda officinalis How.
    2,8-Dihydroxy-1-methoxyanthracene-9,10-dione
  • HY-N17453
    (+)-Mornaphthoate E 2409077-07-0
    (+)-Mornaphthoate E is a growth inhibitor that suppresses cancer cell proliferation. It can be used in research on cancers such as lung cancer and breast cancer.
    (+)-Mornaphthoate E
  • HY-N17842
    2,5,8-Trihydroxy-1-methoxyanthraquinone 2056284-22-9
    2,5,8-Trihydroxy-1-methoxyanthraquinone (Compound 1) is an anthraquinone found in the roots of Morinda officinalis.
    2,5,8-Trihydroxy-1-methoxyanthraquinone
  • HY-N17841
    1,3,8-Trihydroxy-2-methoxyanthraquinone 108637-82-7
    1,3,8-Trihydroxy-2-methoxyanthraquinone is an anthraquinone found in the roots of Morinda officinalis How. 1,3,8-Trihydroxy-2-methoxyanthraquinoneand inhibits LPS (HY-D1056)-stimulated nitric oxide production.
    1,3,8-Trihydroxy-2-methoxyanthraquinone